The Native Antigen Company
Biotechnology-Research
Website
Company Tagline
Critical Reagents for Human Health
Industry Category
Business Keywords
Company Description
The Native Antigen Company is a leading provider of critical reagents for human health, specializing in biotechnology research and the development and manufacturing of infectious disease antigens from bacteria and viruses. Utilizing a proprietary mammalian expression system, The Native Antigen Company produces recombinant forms of these antigens for both research and development purposes, as well as on a bulk scale for IVD manufacturers to incorporate into their immunoassays.
The Native Antigen Company's research and development team possesses particular expertise in flavivirus biology, pioneering the development of mammalian expressed Dengue virus NS1 antigens and Zika virus NS1. Additionally, The Native Antigen Company offers a range of Virus-like particles, finding increasing applications as antigens for IVD applications. Located at Langford Locks, Kidlington, Oxford, Oxfordshire OX5 1LH, GB, The Native Antigen Company continues to develop cutting-edge antigens, using these antigens to raise highly specific monoclonal antibodies and to develop immunoassays.
Furthermore, The Native Antigen Company offers contract-based services for customers seeking a reliable source of high-quality recombinant or native protein. The Native Antigen Company is dedicated to advancing human health through innovative biotechnology solutions. We invite the manager of The Native Antigen Company to create a customized and exclusive company showcase and product listing on our platform to further enhance their commercial development.
The Native Antigen Company est un fournisseur de premier plan de réactifs essentiels pour la santé humaine, spécialisé dans la recherche biotechnologique et le développement et la fabrication d'antigènes de maladies infectieuses provenant de bactéries et de virus. Utilisant un système d'expression mammalien exclusif, The Native Antigen Company produit des formes recombinantes de ces antigènes à des fins de recherche et développement, ainsi qu'à grande échelle pour que les fabricants de DIV les incorporent dans leurs immunoessais.
L'équipe de recherche et développement de The Native Antigen Company possède une expertise particulière dans la biologie des flavivirus, étant pionnière dans le développement d'antigènes NS1 du virus de la dengue exprimés chez les mammifères et du virus Zika NS1. De plus, The Native Antigen Company propose une gamme de particules pseudo-virales, qui trouvent de plus en plus d'applications en tant qu'antigènes pour les applications DIV. Située à Langford Locks, Kidlington, Oxford, Oxfordshire OX5 1LH, GB, The Native Antigen Company continue de développer des antigènes de pointe, en utilisant ces antigènes pour produire des anticorps monoclonaux hautement spécifiques et pour développer des immunoessais.
De plus, The Native Antigen Company offre des services contractuels aux clients à la recherche d'une source fiable de protéines recombinantes ou natives de haute qualité. The Native Antigen Company se consacre à l'avancement de la santé humaine grâce à des solutions biotechnologiques innovantes. Nous invitons le responsable de The Native Antigen Company à créer une vitrine d'entreprise et une liste de produits personnalisées et exclusives sur notre plateforme afin d'améliorer encore leur développement commercial.
Key Personnel / Employees
Compare Companies Side by Side
Compare The Native Antigen Company with 1 companies in Biotechnology-Research
| Comparison Field |
The Native Antigen Compan...Main Company |
SYnAbsView Profile |
|---|---|---|
|
Founded Year
|
— | 2015 |
|
Company Size
|
— | 2-10 |
|
City
|
Oxford, Oxfordshire | Charleroi, Walloon Region |
|
Country
|
United Kingdom | |
|
Skills & Keywords
Comparing with main company
|
15 Total Skills
infectious disease antigens
recombinant proteins
IVD
immunoassays
monoclonal antibodies
flavivirus biology
biotechnology research
protein purification
contract development
Immunoassay development
zika virus R&D
mammalian recombinant protein expression
contract research
Monoclonal antibodies
Dengue virus
|
11 Total
11 Unique
Unique Skills:
Antibody purification
Antigen synthesis
Custom generation of mAbs
Custom manufacturing
Guinea pig mAbs
High affinity mAbs
+5
|
2
Total Companies2015
Oldest Founded1
Countries26
Unique SkillsSimilar Companies
Other organizations in the same industry
Oxcia AB (publ)
Biotechnology-ResearchBreakthrough therapies targeting DNA Damage Response, aiming to cure cancer and inflammation
American CryoStem Corporation
Biotechnology-ResearchTranslating Technologies into Therapeutic Treatments™
TheraCea Pharma
Biotechnology-ResearchUnleash the Power of Personalized Medicine
Alternative Company Names
This company is also known as